Overview

A Study to Test Bioequivalence Between One Test Formulation of Ibuprofen and Two Reference Treatments

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess bioequivalence between one test and two reference formulations used for treatment of headaches and temporary relief of pain.
Phase:
Phase 1
Details
Lead Sponsor:
McNeil AB
Treatments:
Ibuprofen